potassium has been researched along with 2-acetylaminofluorene in 1 studies
*2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines. [MeSH]
*2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blanck, A; Gustafsson, JA; Hällström, IP; Liao, DZ | 1 |
1 other study(ies) available for potassium and 2-acetylaminofluorene
Article | Year |
---|---|
Expression of the c-jun, jun-B, ets-2 and liver regeneration factor-1 (LRF-1) genes during promotion and progression of rat liver carcinogenesis in the resistant hepatocyte model.
Topics: 2-Acetylaminofluorene; Activating Transcription Factor 3; Animals; Carcinogens; Disease Models, Animal; Disease Progression; DNA-Binding Proteins; Female; Gene Expression; Genes, jun; Liver; Liver Neoplasms, Experimental; Male; Proto-Oncogene Protein c-ets-2; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; Repressor Proteins; Trans-Activators; Transcription Factors | 1996 |